We at Nivad have created a knowledge-based company proficient in the development of Biopharmaceutical. We have developed and marketed HPV, Influenza vaccines and have developed the technical knowledge for the pneumococcal conjugate vaccine, rotavirus vaccine, and herpes zoster vaccine that are expected to be marketed by 2024 in Iran. 
In terms of quality, all of these vaccines are similar to vaccines on the international market. These 5 vaccines are amongst the 7 top vaccines produced globally, hence giving them approximately 80% of the world vaccine market.

Nivad Pharmed Salamat

Org chart

Teams

Offices